Global Biopsy Guidance System Market Size & Outlook
Global biopsy guidance system market, 2016-2028 (US$M)
Related Markets
Global biopsy guidance system market highlights
- The global biopsy guidance system market generated a revenue of USD 969.6 million in 2021 and is expected to reach USD 1,383.5 million by 2028.
- The market is expected to grow at a CAGR (2022 - 2028) of 5.2% by 2028.
- In terms of segment, stereotactic guided biopsy accounted for a revenue of USD 385.1 million in 2021.
- Ultrasound Guided Biopsy is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2021.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2022 to 2028.
Global data book summary
| Market revenue in 2021 | USD 969.6 million |
| Market revenue in 2028 | USD 1,383.5 million |
| Growth rate | 5.2% (CAGR from 2021 to 2028) |
| Largest segment | Stereotactic guided biopsy |
| Fastest growing segment | Ultrasound Guided Biopsy |
| Historical data covered | 2016 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy |
Other key industry trends
- In terms of revenue, the North America accounted for 45.4% of the global biopsy guidance system market in 2021.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2028.
- By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 12.2 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopsy Guidance System Market Scope
Biopsy Guidance System Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global biopsy guidance system market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopsy guidance system market will help companies and investors design strategic landscapes.
Stereotactic guided biopsy was the largest segment with a revenue share of 39.72% in 2021. Horizon Databook has segmented the Global biopsy guidance system market based on stereotactic guided biopsy, ultrasound guided biopsy, mri guided biopsy covering the revenue growth of each sub-segment from 2016 to 2028.
- Global Biopsy Guidance System Product Outlook (Revenue, USD Million, 2016-2028)
- Stereotactic Guided Biopsy
- Ultrasound Guided Biopsy
- MRI Guided Biopsy
- Global Biopsy Guidance System Application Outlook (Revenue, USD Million, 2016-2028)
- Brain Biopsy
- Breast Biopsy
- Others
- Global Biopsy Guidance System End Use Outlook (Revenue, USD Million, 2016-2028)
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Research and Academic Institutes
Reasons to subscribe to Global biopsy guidance system market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biopsy guidance system market databook
-
Our clientele includes a mix of biopsy guidance system market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biopsy guidance system market , including forecasts for subscribers. This global databook contains high-level insights into Global biopsy guidance system market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Global biopsy guidance system market size, by regions, 2016-2028 (US$M)
Top 10 countries: Biopsy guidance system market size, 2021 (US$M)
Global biopsy guidance system market share, by product, 2021 & 2028 (%, US$M)
Biopsy guidance system market: Opportunity assessment by country
Global biopsy guidance system market, by region, 2021 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
